News

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...
Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...
Optum and Illumina Inc. researchers documented that less than half of patients with newly diagnosed advanced cancers received any biomarker testing before starting treatment, a gap that persisted ...
Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Dipika Kakkar will soon begin targeted therapy—a part of her liver cancer treatment—a month after she underwent surgery for ...
Targeted therapy drugs for prostate cancer precisely attack cancer cells and stop them from growing and spreading. They give you a personalized type of treatment that’s based on the genetic ...
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...
Prior to the Uveitis (Sycamore) Study, there were few evidence-based therapies for children with moderate to severe uveitis, leading to many suffering serious visual complications and often blindness.
Scientists find potential breakthrough for androgenetic alopecia using adipose-derived stem cells with ATP molecules, showing ...
Belimumab, one of only three new medications approved for lupus in the past 60 years, also is a targeted therapy. It blocks a cytokine called B lymphocyte stimulator, or BLyS ...